“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Front Page » Business » Industry » U.S. Vaccine Market Forecast at $17.4 Billion by 2018
Text size:

U.S. Vaccine Market Forecast at $17.4 Billion by 2018

The value of the market for vaccines in the United States will reach $17.4 billion in 2018, according to a study published by Transparency Market Research of Albany, NY. If accurate, the projection would represent a compound annual growth rate (CAGR) of 5.3% during 2012-2018. TMR estimated the US vaccine market at $12.8 billion in 2012.1 2 3

TMR attributes its optimistic forecast to “technological advancements and strong support from governments and other active organizations such as GAVI (Global Alliance for Vaccines and Immunization) and WHO (World Health Organization).” The U.S. market is “witnessing an increasing trend towards development of personalized vaccines and novel vaccines that cures infectious diseases, allergies, and cancers. Additionally, the “[vaccine] industry will undergo continuous improvements in delivery methodologies, vaccine design, and manufacturing in large-scale processes.”3 

The report, titled “U.S. Vaccine Market (Human Vaccines: Hepatitis, Influenza, Meningococcal, Pneumococcal, HPV, Combination Vaccines; Animal Vaccines: Canine, Feline, Porcine, Bovine, Ovine, Poultry and Equine)—Industry Analysis, Size, Share, Growth, Trends and Forecast 2014-2020,” breaks down the market into human and animal vaccines.2

The report segments the human vaccines market by type—pediatric and adult—and by antigen—heptatitis A & B, influenza, meningococcal, pneumococcal, human papillomavirus (HPV), combination vaccines (DTaP, DTaP-Hep B-IPV, DTaP-IPV and DTaP-IPV), and others. Primary manufacturers of human vaccines in the U.S. are Sanofi-Pasture, GlaxoSmithKline, Pfizer, Merck, Novartis, and Sanofi-Aventis.1

The report segments the animal vaccines market by animal type—companion animal and livestock. Under the companion animal segment, there are the canine and feline markets. Under livestock, the markets include orcine, bovine, ovine, poultry, and equine.2 The main manufacturers of animal vaccines in the U.S. include Merial (Sanofi-Aventis), Novartis Animal Health, Intervet/Schering-Plough (Merck), and Pfizer Animal Health.1

The human vaccine market is, by far, the larger of the two segments. It accounted for 80% of the market share in 2012 and is expected to continue to dominate the market for the foreseeable future.1

The growth of the human vaccines market is being fueled primarily by pediatric vaccines. TMR notes, “The segment of pediatric vaccines currently has an impressive share of the market and holds good future prospects owing to government compulsion for immunizing children in the U.S.”1

A study earlier this year by Tufts University’s Center for the Study of Drug Development (CSDD) forecast worldwide annual sales of vaccines will hit $40 billion by 2020.4


4 Responses to U.S. Vaccine Market Forecast at $17.4 Billion by 2018

  1. Nomad Reply

    December 11, 2015 at 4:03 am

    I love it when the hyper-vax/anti-choice tyrants say that vaccine revenue is a small percentage of the total profits of Big Pharma. Yeah…right, we’re still talking about BILLIONS of dollars guaranteed, and the CDC does all the advertising and fearmongering for them. What a deal!

    Also, let’s no forget all the vaccine-induced diseases (e.g., neurological disorders, autoimmune diseases, childhood cancers, etc.) that will in many cases require medical treatment and drugs. The same drugs manufactured by the pharma companies that make the vaccines. How convenient is that!

    I recently lost a family member to complications from a vaccine-induced autoimmune disease. Expensive treatments and drugs to stay alive. Big Pharma made a nice profit on the fatal disease they caused in the first place!

    Vaccines = chemical warfare on the human race!

  2. Harris Glasser Reply

    December 11, 2015 at 8:42 pm

    You and your children are the pin cushions for the money they’re banking.

    When did all these epidemics start, that laws are being made for mandatory vaccinations. They just passed a law for all Vets to be vaccinated.

    Wake up people…………now they’re saying pregnant women should be vaccinated. Now the unborn they’re after.

    Stop this madness

  3. Ronald Hollis Reply

    December 15, 2015 at 8:19 am

    Thank you Nomad for your insightful comment. Also, there is no needed expense for insurance and lawyers because taxpayers cover their liability. What a sweet deal big Pharma has.

  4. Libbie Oliver Reply

    February 7, 2016 at 8:38 pm

    Check out how many $Billions by Pharma Companies are stored offshore to avoid taxes. http://www.bloomberg.com/news/articles/2015-03-04/u-s-companies-are-stashing-2-1-trillion-overseas-to-avoid-taxes

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>